These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 6124221)

  • 1. The neuroleptic malignant syndrome.
    Smego RA; Durack DT
    Arch Intern Med; 1982 Jun; 142(6):1183-5. PubMed ID: 6124221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroleptic malignant syndrome complicated by disseminated intravascular coagulation.
    Eles GR; Songer JE; DiPette DJ
    Arch Intern Med; 1984 Jun; 144(6):1296-7. PubMed ID: 6732389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neuroleptic malignant syndrome].
    Sczesni B; Schröder J; Becker H; Przuntek H
    Wien Klin Wochenschr; 1991; 103(1):1-7. PubMed ID: 1673041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroleptic malignant syndrome: a review of literature].
    Crespo Facorro B; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(5):273-8. PubMed ID: 8553925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroleptic malignant syndrome.
    Caroff SN
    J Clin Psychiatry; 1980 Mar; 41(3):79-83. PubMed ID: 6101595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluphenazine-induced neuroleptic malignant syndrome in a schizophrenic patient.
    Aruna AS; Murungi JH
    Ann Pharmacother; 2005 Jun; 39(6):1131-5. PubMed ID: 15840734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroleptic malignant syndrome.
    Schrader G; Wong C; Russell R; Goldney RD
    Med J Aust; 1981 Oct; 2(9):494. PubMed ID: 6119606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathophysiology and therapy of malignant neuroleptic syndrome].
    Weller M; Kornhuber J
    Nervenarzt; 1992 Nov; 63(11):645-55. PubMed ID: 1361662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.
    Harsch HH
    J Clin Psychiatry; 1987 Aug; 48(8):328-33. PubMed ID: 2886491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection and management of the neuroleptic malignant syndrome.
    Bond WS
    Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
    Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
    Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroleptic malignant syndrome. A priority system.
    Neppe VM
    S Afr Med J; 1984 Mar; 65(13):523-5. PubMed ID: 6143410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome: a case report.
    Fekadu A; Wakwoya A
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
    Tsai JH; Yang P; Yen JY; Chen CC; Yang MJ
    Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD; Pedersen S
    Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic malignant syndrome: a review and report of six cases.
    Kasantikul D; Kanchanatawan B
    J Med Assoc Thai; 2006 Dec; 89(12):2155-60. PubMed ID: 17214072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic malignant syndrome.
    McHugh TP
    J S C Med Assoc; 1992 Jun; 88(6):303-6. PubMed ID: 1352559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.